Ontology highlight
ABSTRACT:
SUBMITTER: Abramson VG
PROVIDER: S-EPMC4235783 | biostudies-literature | 2014 Sep
REPOSITORIES: biostudies-literature
Abramson Vandana G VG Mayer Ingrid A IA
Current breast cancer reports 20140901 3
Triple-negative breast cancers (TNBCs) are known to be an aggressive group of breast cancers with higher rates of relapse stage for stage compared to ER/PR positive and HER2 positive breast cancers despite optimal loco-regional and systemic therapies. To date, not a single targeted therapy has been approved for the treatment of TNBC, and cytotoxic chemotherapy remains the standard systemic treatment. Recently, gene expression analyses identified six distinct TNBC subtypes, each displaying a uniq ...[more]